Advertisement
Screener

ORAMED PHARMACEUTICALS INC. (ORMP) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

1.9 / 5 stars · 28/74 Roast Me

ORAMED PHARMACEUTICALS INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

ORAMED PHARMACEUTICALS INC. (ORMP) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.47 million for the 12-month period ending 2014-08-31, per its 10-K filed 2014-11-14.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2014-11-14

  • ORAMED PHARMACEUTICALS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2014 was $1.47M, a 104.17% increase from fiscal 2013.
  • ORAMED PHARMACEUTICALS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2013 was $719.00K, a 165.31% increase from fiscal 2012.
  • ORAMED PHARMACEUTICALS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2012 was $271.00K.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2014-08-31$1.47M
10-K · filed 2014-11-14
2013-08-31$719.00K
10-K · filed 2014-11-14
2012-08-31$271.00K
10-K · filed 2014-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
PepGen Inc. (PEPG)United States$0.186B-1.73
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B